1832 Asset Management’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,686
| Closed | -$7.47K | – | 788 |
|
|
2024
Q2 | $7.47K | Hold |
2,686
| – | – | ﹤0.01% | 784 |
|
|
2024
Q1 | $9.75K | Hold |
2,686
| – | – | ﹤0.01% | 757 |
|
|
2023
Q4 | $3.36K | Hold |
2,686
| – | – | ﹤0.01% | 775 |
|
|
2023
Q3 | $2.69K | Hold |
2,686
| – | – | ﹤0.01% | 798 |
|
|
2023
Q2 | $1.96K | Hold |
2,686
| – | – | ﹤0.01% | 813 |
|
|
2023
Q1 | $7.31K | Hold |
2,686
| – | – | ﹤0.01% | 818 |
|
|
2022
Q4 | $6.61K | Buy |
+2,686
| New | +$6.61K | ﹤0.01% | 829 |
|
|
2022
Q2 | – | Sell |
-2,686
| Closed | -$9K | – | 890 |
|
|
2022
Q1 | $9K | Buy |
+2,686
| New | +$9K | ﹤0.01% | 847 |
|